Partial and Transient Clinical Response to Omalizumab in IL-21-Induced Low STAT3-Phosphorylation on Hyper-IgE Syndrome
DOI: 10.1155/2019/6357256
Cesar Daniel Alonso-Bello,
Diana Andrea Herrera-Sánchez,
Fernando Lozano-Pati?o,
Julio César Alcántara-Montiel,
Laura Berrón-Ruiz,
Leopoldo Santos-Argumedo,
Mario Alberto Ynga-Durand,
María Eugenia Vargas-Cama?o,
María Isabel Castrejón-Vázquez,
María del Carmen Jiménez-Martínez,
Sagrario Hierro-Orozco
Abstract:
Full-Text